| Page Range | 58488-58489 | |
| FR Document | 2015-24625 |
[Federal Register Volume 80, Number 188 (Tuesday, September 29, 2015)] [Notices] [Pages 58488-58489] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-24625] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. FDA-2014-M-2375, FDA-2015-M-0909, FDA-2015-M-0199, FDA- 2015-M-0200, FDA-2015-M-0201, FDA-2015-M-0228, FDA-2015-M-0266, FDA- 2015-M-0267, FDA-2015-M-0431, FDA-2015-M-0502, FDA-2015-M-0690, FDA- 2015-M-0738, FDA-2015-M-0910] Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications AGENCY: Food and Drug Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA) is publishing a list of premarket approval applications (PMAs) that have been approved. This list is intended to inform the public of the availability of safety and effectiveness summaries of approved PMAs through the Internet and the Agency's Division of Dockets Management. ADDRESSES: Submit written requests for copies of summaries of safety and effectiveness data to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. Please cite the appropriate docket number as listed in table 1 when submitting a written request. See the SUPPLEMENTARY INFORMATION section for electronic access to the summaries of safety and effectiveness. FOR FURTHER INFORMATION CONTACT: Melissa Torres, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 1650, Silver Spring, MD 20993-0002, 301-796-5576. SUPPLEMENTARY INFORMATION: I. Background In accordance with sections 515(d)(4) and (e)(2) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 360e(d)(4) and (e)(2)), notification of an order approving, denying, or withdrawing approval of a PMA will continue to include a notice of opportunity to request review of the order under section 515(g) of the FD&C Act. The 30-day period for requesting reconsideration of an FDA action under Sec. 10.33(b) (21 CFR 10.33(b)) for notices announcing approval of a PMA begins on the day the notice is placed on the Internet. Section 10.33(b) provides that FDA may, for good cause, extend this 30-day period. Reconsideration of a denial or withdrawal of approval of a PMA may be sought only by the applicant; in these cases, the 30-day period will begin when the applicant is notified by FDA in writing of its decision. The regulations provide that FDA publish a quarterly list of available safety and effectiveness summaries of PMA approvals and denials that were announced during that quarter. The following is a list of approved PMAs for which summaries of safety and effectiveness were placed on the Internet from January 1, 2015, through March 31, 2015. There were no denial actions during this period. The list provides the manufacturer's name, the product's generic name or the trade name, and the approval date. Table 1--List of Safety and Effectiveness Summaries for Approved PMAs Made Available From January 1, 2015, Through March 31, 2015 ---------------------------------------------------------------------------------------------------------------- PMA No., Docket No. Applicant Trade name Approval date ---------------------------------------------------------------------------------------------------------------- P980040/S049, FDA-2014-M-2375....... Abbott Medical Optics, Inc.. TECNIS[supreg] multifocal 1- 12/17/2014 piece intraocular lens. P140010, FDA-2015-M-0199............ Medtronic, Inc.............. IN.PACTTM AdmiralTM 12/30/2014 Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter. P130019, FDA-2015-M-0201............ EnteroMedics, Inc........... Maestro[supreg] Rechargeable 1/14/2015 System. P130025, FDA-2015-M-0200............ Koning Corp................. Koning Breast CT (Model CBCT 1/14/2015 1000). P060001/S020, FDA-2015-M-0228....... ev3, Inc.................... Prot[eacute]g[eacute]TM GPS 1/21/2015 Self-Expanding Peripheral Stent System. H140001, FDA-2015-M-0267............ ABIOMED, Inc................ Impella RP System........... 1/23/2015 [[Page 58489]] P140017, FDA-2015-M-0266............ Medtronic, Inc.............. MelodyTM Transcatheter 1/27/2015 Pulmonary Valve (TPV) and EnsembleTM Transcatheter Valve Delivery System. P130023, FDA-2015-M-0431............ Cohera Medical, Inc......... TissuGlu[supreg] Surgical 2/3/2015 Adhesive. P010047/S036, FDA-2015-M-0502....... NeoMend, Inc................ ProGelTM Pleural Air Leak 2/13/2015 Sealant. P140018, FDA-2015-M-0690............ Covidien, LLC............... VenaSealTM Closure System... 2/20/2015 H130001, FDA-2015-M-0909............ Biologics Consulting Group, Lixelle Beta 2-microglobulin 3/5/2015 Inc.. Apheresis Column. P110024, FDA-2015-M-0738............ Advanced Circulatory ResQCPRTM System............ 3/6/2015 Systems, Inc.. P130013, FDA-2015-M-0910............ Boston Scientific Corp...... WATCHMANTM Left Atrial 3/13/2015 Appendage (LAA) Closure Technology. ---------------------------------------------------------------------------------------------------------------- II. Electronic Access Persons with access to the Internet may obtain the documents at http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/PMAApprovals/default.htm. Dated: September 23, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015-24625 Filed 9-28-15; 8:45 am] BILLING CODE 4164-01-P
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Contact | Melissa Torres, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 1650, Silver Spring, MD 20993-0002, 301-796-5576. | |
| FR Citation | 80 FR 58488 |